However, prostate cancer could overcome hormone deprivation strategies through several cellular mechanisms, such as intratumoral androgen production and the production of ligand-independent androgen receptor splice variants, known clinically as castration-resistant prostate cancer. The gene discussed is AR; the disease is prostate cancer.